Scientific data from clinical trials: Investigators' responsibilities and rights

Hiram C. Polk, Talmadge A. Bowden, Layton F. Rikkers, Charles M. Balch, Claude H. Organ, John A. Murie, Walter J. Pories, Markus W. Buechler, John P. Neoptolemos, Victor W. Fazio, Seymour I. Schwartz, John L. Cameron, Keith A. Kelly, Jay L. Grosfeld, David W. McFadden, Wiley W. Souba, Basil A. Pruitt, K. Wayne Johnston, Robert B. Rutherford, Maurice E. ArreguiCarol E.H. Scott-Conner, Andrew L. Warshaw, Michael G. Sarr, Alfred Cuschieri, Bruce V. MacFadyen, Ronald K. Tompkins

Research output: Contribution to journalArticlepeer-review

2 Scopus citations

Abstract

Based on recent reports, there are increasing concerns about the control of the scientific data obtained from clinical trials sponsored by industry. Many of the problems encountered are the result of restrictions contained in the research contracts that participating investigators are asked to sign. A number of solutions have been suggested to ensure the integrity of clinical trials, including the establishment of appropriately constituted trial oversight committees, negotiating noninterference pledges from industry sponsors, and creating proactive support of investigators' rights by organized medicine.

Original languageEnglish (US)
Pages (from-to)639-640
Number of pages2
JournalArchives of Surgery
Volume137
Issue number6
StatePublished - Jun 18 2002

ASJC Scopus subject areas

  • Surgery

Fingerprint Dive into the research topics of 'Scientific data from clinical trials: Investigators' responsibilities and rights'. Together they form a unique fingerprint.

Cite this